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Available online 10 December 2010Abstract Maintaining stable differentiated somatic cell function in culture is essential to a range of biological endeavors. However,
current technologies, employing, for example, primary hepatic cell culture (essential to the development of a bio-artificial liver and
improveddrugand toxicology testing), are limitedby supply, expense, and functional instability evenonbiological cell culture substrata.
As such, novel biologically active substrates manufacturable to GMP standards have the potential to improve cell culture-based assay
applications.Currently hepatic endoderm(HE) generated frompluripotent stemcells is a genotypically diverse, cheap,and stable source
of “hepatocytes”; however, HE routine applications are limited due to phenotypic instability in culture. Therefore a manufacturable
subcellular matrix capable of supporting long-term differentiated cell function would represent a step forward in developing scalable
and phenotypically stable hESC-derived hepatocytes. Adopting an unbiased approachwe screened polymermicroarrays and identified a
polyurethanematrix which promoted HE viability, hepatocellular gene expression, drug-induciblemetabolism, and function. Moreover,
the polyurethane supported,when coatedon a clinically approvedbio-artificial livermatrix, long-termhepatocyte function and growth.
In conclusion, our data suggest that an unbiased screening approach can identify cell culture substrate(s) that enhance the phenotypic
stability of primary and stem cell-derived cell resources.
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93Polymer matrix promotes hepatocyte drug metabolismIntroductionMaintaining stable differentiated somatic cell function in
culture is essential to a range of biological endeavors. This is
particularly important if human embryonic stem cells (hESC)
and induced pluripotent stem cell (iPSC)-derived differenti-
ated cells are to achieve their full potential as scalable
cellular resources. The application of stem cell-derived
hepatic endoderm (HE), as predictive in vitro models, is
important given the current shortfalls in human liver models
employed by Pharma and biotech to date. As such, state of
the art drug and toxicology testing is far from perfect with a
number of hurdles to overcome.
Liver cells (hepatocytes) metabolise most compounds and
therefore can be used to predict liver metabolism and drug
toxicity of a drug/compound. Howevermostmetabolic models
are typically based on rodent liver (for reasons of supply and
uniformity) and therefore only approximately predict human
drug metabolism (Guillouzo, 1998; Maurel, 1996). As a result
many drug trials have had to be terminated because such
systems simply failed to predict human drug toxicity. The
alternatives to rodent hepatocytes are cryopreserved or
freshly isolated primary human hepatocytes. However, their
widespread use is limited by supply, expense, variability in
quality, and the diminishing function and viability following
isolation and cryopreservation. However, despite these
limitations they continue to serve as the industrial gold
standard. Thus, there is an unmet need for the development
of more accurate and predictive toxicity models.
hESCs represent a pluripotent cell population able to
generate all primary cell types in vitro (Thomson et al.,
1998; Reubinoff et al., 2000). The ability to derive unlimited
amounts of human HE from pluripotent stem cells constitutes
an attractive and scalable resource which holds great
potential. The deployment of this resource in the drug
discovery process has the potential to streamline and
standardize the predictive process and therefore impacting
on the costs of drug attrition. Although very promising (Hay et
al., 2008; Basma et al., 2009; Agarwal et al., 2008; Baharvand
et al., 2006; Duan et al., 2007; Lavon et al., 2004; Touboul et
al., 2010; Hannoun et al., 2010; Greenhough et al., 2010;
Payne et al., 2011), hESC-derived HE, like primary human
hepatocytes, also demonstrate reduced long-term viability
and function in prolonged tissue culture, meaning that the
advantages gained in uniformity, supply, integrity, and
specificity have to date been offset by inflexibility necessi-
tated by short-term culture models.
The identification of a scalable conventional substrate(s)
which facilitates long-term hepatocyte function has the
potential to overcome these issues. Additionally, such a
resource would aid endeavors to develop a human cell-based
bio-artificial liver, which to date have failed because of poor
cell availability, viability, and long-term function. Moreover,
the development/application of a screening technology, for
cellular support matrices, to stem cell-derived differentiated
cells would also permit the rapid clinical and industrial
translation of stem cell-derived products. With that in mind,
and as a proof of concept for our approach, we employed
polymer microarrays to identify novel cellular supports and
substrates which display subtle properties supporting differ-
entiated cell function.Using an unbiased approach and capitalising on our recent
demonstration that hESCs can be differentiated to form HE in
vitro (Hay et al., 2008), we employed the polymer microarray
screening approach (Pernagallo et al., 2009; Tourniaire et al.,
2006; Thaburet et al., 2004) to discover novel extracellular
substrate(s). We identified a simple polyurethane which not
only provides long-term hepatic support, but does so in a
manner in which the hepatocytes are fully functional and
exhibit superior drug inducibility to freshly isolated primary
human hepatocytes (FPHH). The data provide proof of concept
that a novel and unbiased approach offers a simple and cost-
effective means of identifying alternatives to complex
xenobiotics. Moreover, such polymers provide a scalable
resource to support differentiated cell function in research,
drug screening, and toxicology and in the longer term,
extracorporeal devices.Results
Polymer library fabrication and screening
Polymer microarrays have been used to identify substrates that
modulate or control cell biology (Meredith et al., 2003; How et
al., 2004; Pernagallo et al., 2009; Tourniaire et al., 2006;
Thaburet et al., 2004). The polymer arrays used in these studies
were fabricated by contact printing 380 polyurethanes and
polyacrylates onto an agarose-coated glass microscope slide
(Pernagallo et al., 2009; Tourniaire et al., 2006). Before printing
in quadruplicate, each library member was dissolved in a
common, nonvolatile solvent N-methyl-2-pyrrolidinone (NMP).
A number of printing parameters, such as inking and printing
time, were optimised in this process to ensure uniformity of
polymer spot within the array. Once printed, the slides were
dried overnight and sterilised by UV irradiation prior to cell
plating. The polymer library was screened for stem cell-derived
hepatic endoderm attachment and long-term function using the
HCS systems and Pathfinder software. Direct differentiation of
hESCs to HE was initiated using a highly efficient tissue culture
model (Hay et al., 2008) (Fig. 1A). On adopting a hepatic fate
(Day 8), HE was detached from the biological extracellular
matrix and replated onto the polymer microarray. Following
replating onto the array, hESC-derived HE was cultured for a
further 9 days under conditions that supported hepatic identity
and differentiation in vitro (Hay et al., 2008). At this point cell
attachment was recorded using phase microscopy (Fig. 1B, A),
with hepatic phenotype assessed by albumin production
(Fig. 1B, B), and compared to culture on Matrigel (Fig. 1B, C)
and an IgG isotype control (Fig. 1B, D).
In order to study hepatic function in further detail and
confirm the results of these experiments, the six hit-selected
polymers (three polyurethanes 134, 212, 223 and three
polyacrylates 2BG9, 9 G7, 3AA7) that supported HE attach-
ment and identity (Table 1) and function were investigated in
detail. Fourteen days following replating (Day 23) onto the
identified polymers (coated 13 mm coverslips) HE synthetic
functionwas screenedand defined by the expression of a panel
of soluble hepatocyte export proteins and compared to hESCs
and FPHHs. Using this impartial strategy, polymer 134 was
identified, in most cases, as an effective cellular matrix which
supported superior hepatic function when compared to hESCs
and FPHHs (Figs. 2A–C). hESC-derived HE on polymer 134
Figure 1 Screening a polymer library. (A) hESCs were differentiated to HE using an efficient differentiation protocol (Hay et al., 2008).
Abbreviations: bFGF, basic fibroblast growth factor; MEF-CM, mouse embryonic fibroblast conditioned medium; KO DMEM, knock out
Dulbecco's modified Eagle medium; DMSO, dimethyl sulfoxide; SR, serum replacement; L-15, Leibovitz's L-15; FCS, fetal calf serum; HGF,
hepatocyte growth factor; OSM, oncostatin M; DAPI, 4′,6-diamidino-2-phenylindole. (B) A, Phase contrast microscopy of cells replated on the
polymer library following 8 days culture in hepatocyte culture medium. Magnification×10. B, Immunofluorescence for human albumin
expression in hepatic endoderm (HE) replated on the polymer spots. C, Immunofluorescence for human albumin in HEmaintained onMatrigel
(MG). D, IgG isotype immunostaining control for human albumin staining. Photographs were taken using a Leica DMIRB; scale bar 100 μm.
94 D.C. Hay et al.exhibited similar fibronectin secretion to FPHHs in these
experiments (Fig. 2C).Extensive characterisation of hESC-derived HE on
polymer 134 and Matrigel
Our further studies focussed on HE morphology, signaling, gene
expression, and drugmetabolism on two extracellularmatrices,
MGand polymer 134 (Fig. 3). MGwas used as our control as it has
previously been shown to improve hepatocyte performance in
vitro (Bissel et al., 1987). HE passaged andmaintained on MG or
polymers 2BG9, 212, 9 G7, 3AA7, and 223 (Day 24), (Fig. 4A,
Supplementary Fig. 1)weregranular. In contrast,HE replatedon
134maintainedaclear hepaticmorphology (Fig. 4A). In linewith
changes in cellular morphology we also observed changes in
general cell signaling and hepatic gene expression. hESC-HETable 1 Summarises the 6 polymer hits and the criteria we
used to assess hepatic identity (n=4)
Polymer Attachment Albumin
2BG9 + +
2I2 + +
9G7 + +
3AA7 + +
223 + +
134 + +
MG + +maintained on polymer 134 displayed increased FAK, Akt, and
ERK signaling, consistent with the cells becoming firmly
attached to the substrate and not undergoing apoptosis. This
was not observed in HE maintained on MG. Although HE plated
on polymer 134 displayed elevated levels of the promitotic
factor ERK and Akt, HE also expressed high levels of cell cycle
inhibitors p15 and p21, consistent with metabolically active
hepatocellular populations locked in a quiescent and therefore
functional state (Fig. 4B). In addition to changes in cell signaling
and cell cycle we also observed changes in hepatocyte gene
expression. The expressions of both N-cadherin and E-cadherin
play important roles in human hepatocyte biology and expres-
sions of both of these were enhanced in hESC-HE maintained on
134 compared with MG. In addition to a more epithelial
phenotype on polymer 134, we also observed increased
expression of hPXR and phospho-PXR. The increased levels of
hPXR were consistent with increased levels of cytochrome P450
(CYP) 3AdetectedbyWesternblotting (Fig. 4B). In order to asses
the role that polymer was playing in CYP3A metabolic activity
key activities on the different extracellular matrices were
analysed compared to cryopreserved primary human hepato-
cytes (CPHHs) and FPHHs. HE maintained on polymer 134
displayed similar CYP3A function to cryopreserved primary
human hepatocytes (PHHs) and increased in CYP3A function
over hESCs (~13-fold) and hESC-derived HEmaintained onMG or
the other polymers tested (~2-fold) (Fig. 4C, Supplementary
Fig. 1). While FPHHs demonstrated superior function (10- to 15-
fold) over both hESC-derived HE on 134 and cryopreserved PHHs
(Fig. 4C, Supplementary Fig. 1). In addition to CYP3A, CYP1A2
activity was induced ~3–7-fold on polymer 134 when compared
with MG, polymer and hESC cultures (Supplementary Fig. 1).
Figure 2 Characterisation of polymer library “hits.” hESCs were
differentiated to hepatic endoderm (HE) using an established
method. At Day 23 hESC-derived HE was incubated in 1 ml of
hepatocyte culture medium for 24 h. The following morning culture
supernatants were harvested and serum protein production was
measured by ELISA and quoted as ng/mg of cellular protein. HE
cultured on polymer 134 exhibited the greatest effect on hepatic
function with an induction of fibrinogen, transthyretin (TTR), and
fibronectin when compared to hESCs and HE on polymers 2BG9,
9 G7, 223, 212, and 3AA7 or Matrigel (MG) matrices (n=3). hESC-HE
exhibited similar fibronectin production to freshly isolated primary
human hepatocytes (FPHH) and greater TTR and fibrinogen
production than FPHHs (n=4). Error bars represent 1 standard
deviation.
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HE maintained on MG and polymer 134 (Fig. 4B).Attachment of hESC-derived HE onto native and
polymer 134-coated bio-artificial liver matrix
The identification of the phospho-form of PXR in HE
maintained on polymer 134 indicated that HE may be drug
inducible. Therefore in order to assess drug inducibility andthe utility of HE in a directly translatable setting, a polyfiber
core (PFC) cell matrix used in a bio-artificial liver (BAL)
device was employed (van de Kerkhore et al., 2002). The PFC
was tested in both its native form and coated with polymer
134. On adopting an hepatic fate (Day 9), HE was detached
from the biological extracellular matrix and replated onto
native or polymer-coated PFC (Fig. 5A uncoated and
polymer-coated BAL matrix Fig. 5C) and cultured for a
further 15 days (Day 24) under conditions that support
hepatic identity, prior to fixation and scanning electron
microscopy (SEM) analysis. hESC-derived HE maintained on
uncoated PFC demonstrated cell attachment and cell
processes resembling stress fibers (Fig. 5B) whereas HE
maintained on polymer 134-coated PFC exhibited a smooth
tissue-like appearance (Fig. 5D) which could be expected to
limit the effects of fluid shear stress on HE in the BAL,
reducing potential inflammatory mediator production.
hESC-derived HE function on native and polymer
134-coated bio-artificial liver matrix
hESC-derived HE was cultured on the different BAL matrices for
13 days, before assessment of HE drug inducibility (Days 22–24).
hESC-derived HE was induced with a range of phenobarbital
concentrations (0.4–5 mM) ormaintained in control medium for
48 h, changing medium daily. At Day 24 HE maintained on both
the PFC support matrices were assessed for CYP3A drug
induction. CYP3A was chosen as it has been estimated to play
a role in the metabolism of approximately 50% of therapeutic
drugs (Keshava et al., 2004) and thereby essential to predictive
drug toxicity and extracorporeal support. At Day 24 the native
matrix supported hepatocyte attachment and function, with a
narrow rangedrug inductionofCYP3A (Fig. 5B, Fig. 6A, light gray
bars). In contrast, hESC-derived HE from both H1 and H9s
replated on polymer 134-coated matrix exhibited phenobarbi-
tal-inducible CYP3A drug metabolism (Fig. 6A, dark gray bars
and Supplementary Fig. 4 black bars) over a broader range. In
both cases hESC-derived HE on BAL matrix and 134-coated BAL
matrix demonstrated superior drug induction to FPHHs (Fig. 6A,
black bars). These data exemplify the value of polymer 134 and
hESC-derived HE both in predictive toxicology and in a BAL
setting. In addition to P450 drug inducibility, we also studied
endocrine and exocrine human liver function by ureagensis (Day
24) and human albumin production (Days 17 to 21) (Figs. 6B and
C). Ureagenesis was significantly improved on polymer 134 HE
(~55-fold) when compared to FPHHs and MAT HE (~2-fold)
(Fig. 6B). Additionally, albumin production in 134 HE was
superior to MAT HE, however it was reduced 100-fold in
comparison to FPHHs (Fig. 6C).
Discussion
In an attempt to improve the quality of hESC-derived HE we
screened polymer libraries for novel and bioactive substra-
ta. Following polymer library screening we identified 6
polymers which supported hepatic attachment and identity
in vitro (Fig. 1). In order to study hepatic function in further
detail the hit polymers were screened for the expression of a
panel of soluble export proteins produced by the liver. From
these studies polymer 134 was identified as the most
effective cellular support (Fig. 2). In addition to changes
Figure 3 vMonomers and structure of polyurethane 134. Diol: poly[1,6-hexanediol/neopentyl glycol/diethylene glycol-alt-(adiptic
acid)]diol (PHNGAD); diisocyanate: 4,4′-methylenebis(phenylisocyanate) (MDI); chain extender: 1,4-butanediol (BD). Molecular ratio:
Diol/diisocyanate/chain extender (0.25/0.50/0.25).
96 D.C. Hay et al.in levels of HE function we also noted gross changes in
cellular morphology with hESC HE replated on 134, exhibit-
ing clear hepatic morphology and canaliculi (Fig. 4). In line
with changes in cellular morphology we also observed major
differences in HE signaling networks, consistent with the
cells remaining hepatic and firmly attached to the substrate
(Fig. 4). In addition, HE maintained on polymer 134
displayed similar CYP3A function to cryopreserved PHHs
which was superior to the all other ECMs tested (Fig. 4,
Supplementary Fig. 1). This being said, both hESC-HE and
cryopreserved PHHs displayed reduced basal function (~10-
to 15-fold) when compared to freshly isolated PHHs.
Although basal function was reduced in vitro, dose-
dependent drug induction of CYP3A drug metabolism was
superior in hESC-derived HE compared to freshly isolated
PHHs (Fig. 6 and Supplementary Fig. 4), indicating that
hESC-derived HE was a more sensitive, and therefore
predictive, model of human liver function in vitro.
The top polyurethanes identified by our approach, 134, 212
and 223, were structurally related comprising the monomers:
(poly[1,6-hexanediol/neopentyl glycol/di(ethyleneglycol)-
alt-adipic acid] diol (PHNGAD), 4,4′-methylenebis(phenyl
isocyanate) (MDI) and 1,4-butanediol (BD)); (poly[1,6-hexane-
diol/neopentyl glycol-alt-adipic acid] diol (PHNAD), 1,6-
diisocyanate) (HDI), and propylene glycol (PG) and (poly[1,6-
hexanediol/neopentyl glycol-alt-adipic acid] diol, 4,4′-methy-Figure 4 Characterisation of HE on polymer 134 andMatrigel (A) hESC
or polyurethane 134. (B) Protein lysates were prepared from HE maint
probed for p-Akt, p-FAK, p-ERK, p15, p21, E-cadherin, N-cadherin, album
MG, displayed increased FAK, Akt, and ERK signaling; cell cycle inhibito
cadherin, expression, and hPXR and Cyp3A expression. In addition HE m
consistent with inducible hPXR protein phophorylation. The levels of
polyurethane 134 and MG. (C) hESC-derived HE was incubated with h
substrate. CYP3A activity was expressed as relative light units (RLU)/mg
cryopreserved (CPHH) and freshly isolated primary human hepatocytes (
the hESC control experiment. 134 HE, CPHH, and FPHH were all increa
denoted *** measured by Students t test in comparison to MG HE culturelenebis(phenyl isocyanate) and octafluoro-1,6-hexandiol
(OFHD), respectively. The monomers PHNAD and PHNGAD
are closely related and thus this common feature appears
important for HE binding and control. However, this feature
alone was insufficient to dictate binding and control as other
polymers in the library containing the monomers PHNAD or
PHNGAD were not identified from the microarray screen. In
general polyurethanes which did not contain an extender did
not bind hepatocyte-like cells. In terms of the three
polyacrylates 2BG9, 9 G7, 3AA7 (monomers methyl methacry-
late (MMA) and ethyleneglycol methacrylate phosphate
(EGMP-H)), (n-butyl methacrylate (BMA) and diethylami-
noethyl acrylate (DEAEA)), and (methoxethyl methacrylate
(MEMA) and 4-vinylpyridine (VP-4)), respectively, very little
correlation can be drawn. Indeed the polymers are structurally
diverse with no commonality between them, with widely
variant functionalities, from phosphate (– vely charged) to a
secondary amine (+ vely charged) to uncharged. Extensive
analysis of the polymer physical parameters and biological
response (using the program SpotFire) failed to show any
correlation. However, many of these monomers have found
applications in cell binding applications; for example, EGMP-H
was used in PEG hydrogels to encapsulate hMSCs (Nuttelmana
et al., 2006), while DEAEA has been identified as a monomer
that promotes cell binding in thermally responsive polymers
(Zhang et al., 2009).-derived hepatic endoderm (HE)morphology plated onMatrigel (MG)
ained on MG or 134. Extracts were Western-blotted, blocked, and
in, hPXR, and Cyp3A. hESC-HE maintained on polymer 134, but not
rs, p15 and p21, expression; adhesion molecule, N-cadherin and E-
aintained on polymer 134 exhibited the presence of an upper band
albumin remained similar on hepatocyte-like cells maintained on
epatocyte culture medium supplemented with 50 μM CYP3A pGlo
protein/ml (n=3) for hESC-derived hepatic endoderm and n=6 for
FPHH). hESC-derived HE and PHHs were significantly different than
sed significantly over MG HE. Pb0.05 is denoted * and Pb0.001 is
s. Error bars represent 1 standard deviation.
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ability to bind proteins, and direct polymer–cell interac-
tions as well as polymer surface topography all undoubt-
edly play a role in controlling and modulating cell
binding.
Polyurethane 134 was identified as the most effective
cellular support compared to Matrigel (MG) and the other
polymers tested. The success of polyurethane 134 may be
due to the fact that the monomer PHNGAD and theextender (BD) serve to modulate physical parameters,
such as elasticity, wettability (Thaburet et al., 2004), and
surface topography, while the hydrophobic nature of MDI
helps to absorb extracellular matrix proteins, but this is
in reality far too simplistic. There are a myriad of
variables that vary during culture and an unbiased
screening approach that looks for desired function, akin
to mRNA profiling or high-throughout screening of small
molecules, is the only practical solution to such a
Figure 5 Replating of HE onto native and polymer-coated bio-artificial liver matrix. hESC-derived hepatic endoderm (HE) was
plated either on an uncoated or a coated polyfiber core (PFC) of the bio-artificial liver (BAL). At Day 24 in culture the cells were fixed
and examined by electron microscopy. (A) The uncoated PFC of the BAL, (B) represents uncoated PFC with HE attached, (C) represents
the polymer-coated PFC, and (D) represents polymer 134-coated PFC with HE attached. Scale bar in panel is 50 μm.
98 D.C. Hay et al.complex system and in this case gave rise to the
discovery of polymer 134.
In conclusion, the ability to derive high-fidelity primary
cell types from hESCs represents an attractive strategy to
develop a more detailed understanding of human biology
in vitro and will undoubtedly play an import role in
regenerative medicine. To this end, we have screened
polymer libraries to identify novel ECMs which play a
supportive role in hepatocyte biology. Using our approach
we have identified a simple and scalable culture polymer
matrix which enhances hepatic phenotype and sensitivity
in vitro.Figure 6 HE function onnative andpolymer-coatedbio-artificial liver
48 h, changing medium and phenobarbital on a daily basis. Control cult
daily. For ELISA experiments hepatic endoderm (HE) was cultured in 12-
collected and measured as described (Hay et al., 2008). (A) hESC-deriv
coated bio-artificial liver matrix (dark gray bars). Drug inducibility of hES
(black bars) throughout. The cultures were incubated in the presence or
to measurement of CYP3A activity using the nonlytic pGlo system. At
(POLARstar optima). Units of activity are expressed as relative light unit
uninduced controls andmeasured by a student's t-test Pb0.01 is denoted
on the uncoated (light gray bars) or on coated bio-artificial liver matrix
hepatocytes (FPHH) (black bars). The cultures were incubated in the
ureagenesis. Urea production activity is quoted atmmol/mg cell protein
FPHH (n=4) (C) Prior to drug induction (Days 17–21) hESC-derived HE
followingmorning culture supernatants were harvested and serum prote
supernatant.HEculturedonpolymer134 (134HE)exhibited superior hum
liver matrix (MAT HE) (n=4). However, human serum albumin produc
denoted *** andmeasured by Students t test in comparison to MAT HE an
represent 1 standard deviation.Materials and methods
Cell culture and differentiationHuman embryonic stem cells (H9 and H1) were cultured and
propagated on MG-coated plates with mouse embryonic
fibroblast conditioned medium (MEF-CM) supplemented with
basic fibroblast growth factor under feeder-free, serum-free
conditions as previously described (Hay et al., 2008).
Differentiation was initiated at 60–70% confluence, by
replacing the MEF-CM with differentiation medium (RPMImatrix. Phenobarbital drug inductionwas carried out fromDay22 for
ures did not receive phenobarbital, but had their medium changed
well plates with 1 ml L-15 for 24 h before culture supernatants were
ed HE was plated either on the uncoated (light gray bars) or on the
C-derived HE cultures was compared to freshly isolated hepatocytes
absence of a known CYP3A inducer, phenobarbital (0.4–5 mM) prior
5 h posttreatment CYP3A activity was measured on a luminometer
s (RLU)/mg protein/ml (n=6). Levels of significance are quoted over
** and Pb0.001 is denoted ***. (B) hESC-derivedHEwas plated either
(dark gray bars) and compared to freshly isolated primary human
presence of ammonium chloride for 4 h prior to measurement of
/h andwas significantly higher in hESC-HE (MAT and 134, n=12) than
was incubated in 1 ml of hepatocyte culture medium for 24 h. The
in production wasmeasured by ELISA and quoted as ng/ml of culture
analbuminproductionwhencompared to theuncoatedbio-artificial
tion was reduced 100-fold when compared to FPHHs. Pb0.001 is
d 134 HE. The graphwas plotted using a logarithmic scale. Error bars
99Polymer matrix promotes hepatocyte drug metabolism1640 containing B27) (both from Invitrogen), 100 ng/ml
activin A (Peprotech), and 50 ng/ml Wnt3a (R&D Systems).
After 72 h (changing medium every day) differentiating cells
were cultured in differentiation medium (SR/DMSO medium:
knockout-DMEM containing 20% serum replacement (SR),
1 mM glutamine, 1% nonessential amino acids, 0.1 mM β-
mercaptoethanol (all from Invitrogen), and 1% dimethyl
sulfoxide (DMSO, Sigma)) for 4 days. At Day 8 in the
differentiation process the cells were removed from their
substrate using a 5 min 37 °C incubation with trypsin/EDTA
(Invitrogen). Following this hepatocyte-like cells were plated
onto the polymer array, polymer-coated coverslips, or MG-
coated plasticware and cultured in maturation medium, L15
medium (Sigma) supplemented with 8.3% fetal calf serum,8.3% tryptose phosphate broth, 10 μM hydrocortisone 21-
hemisuccinate, 1 μM insulin (Sigma), and 2 mM glutamine
(Invitrogen) containing 10 ng/ml hepatocyte growth factor
(Peprotech) and 20 ng/ml oncostatin M (R&D Systems). The
medium was changed every second day during maturation till
characterisation at Day 17. hESC-derived HE was incubated in
the presence or absence of phenobarbital (Sigma) (range 0.4–
5 mM) for 48 h prior to measurement of CYP3A activity.Primary human hepatocyte thaw and culture
Cryopreserved primary human hepatocytes (Lonza) were
thawed and DMSO was removed slowly at 4 °C by doubling
Table 2 Antibodies used in Western blot studies
Antigen Company Dilution
p-FAK Epitomics 1:5000
p-Akt Cell Signaling 1:4000
p-Erk Cell Signaling 1:4000
P15 Cell Signaling 1:1000
P21 Santa Cruz 1:500
E-Cad DAKO 1:1000
N-Cad DAKO 1:1000
h-PXR ABCAM 1:250
CYP3A Dundee University 1:250
Albumin Sigma 1:1000
B-Actin Santa Cruz 1:2000
Secondary DAKO Anti Mouse 1:2000
Secondary DAKO Anti Sheep 1:2000
Secondary DAKO Anti Rabbit 1:2000
100 D.C. Hay et al.dilutions of fresh L-15 medium. Cryopreserved PHHs were
cultured in the same manner as hESC-derived HE (Hay et al.,
2008). PHH basal drug metabolism was measured using the
pGlo assay (Promega) described below. FPHHs were pur-
chased from Invitrogen (HMFS01) and maintained as per the
manufacturer's instructions (Williams E A1217601 and the
supplement pack CM4000) on Matrigel (BD)-coated 12-well
plates. Both cryopreserved and freshly isolated cultures
were seeded at 105 viable cells/cm2. The cultures were
incubated in the presence or absence of phenobarbital
(Sigma; range 0.4–5 mM) within 24 h of replating prior to
measurement of CYP3A activity.
Immunostaining
Monolayer cultures were fixed in ice-cold methanol at
-20 °C for 10 min. After blocking with PBS containing 10%
BSA, cells were incubated with primary antibody (human
serum albumin 1:500, Sigma) at 4 °C overnight, followed by
30 min incubation with appropriate secondary antibody at
room temperature.
Measurement of hepatocyte export proteins
Day 23 hESC derivedHE, FPHHs, and hESCswere cultured in 12-
well plates with 1 ml L-15. Following 24 h culture the super-
natants were collected for analysis. Hepatic export proteins
were measured by enzyme-linked immunoabsorbant assay
(ELISA) as previously described and normalized to total cell
protein (mg) (Wheelhouse et al., 2006;O'Riordain et al., 1995).
Cytochrome p450 function
CYP3A and CYP1A2 activities were assessed using the pGlo kit
from Promega and carried out as per the manufacturer's
instructions for nonlytic CYP450 activity estimation (http://
www.promega.com/tbs/tb325/tb325.pdf). CYP Activities are
expressed as relative light units (RLU) per milligram of protein.
Western blotting
Western blottingwas carried out as previously described (Hay et
al., 2007). Primary and secondary antibody dilutions and
suppliers are shown in Table 2.
Polymer microarray fabrication
Three hundred and eighty members of a presynthesised
polyurethane and polyacrylate library were “spotted” on
aminoalkylsilane-treated glass slides, previously coated with
agarose to impede unspecific cell adhesion (Pernagallo et al.,
2009; Tourniaire et al., 2006) (for a full list of the polymers used
see Supplementary Fig. 2). Coating with agarose was achieved
by manually dip-coating the slide in agarose Type I-B (1% w/v in
deionisedwater at 65 °C), followedby removal of the coating on
the bottom of the side by wiping with a clean piece of tissue.
Subsequently, the slides were dried overnight at room
temperature in a dust-free environment. Polymers for contact
printing were prepared by dissolving 10 mg of polymer in 1 ml of
the nonvolatile solvent N-methyl-2-pyrrolidinone. Polymer
microarrays were then fabricated by contact printing (Q-ArrayMini microarrayer) with 32 aQu solid pins (K2785, Genetix) using
the polymer solutions placed in polypropylene 384-well micro-
plates (X7020, Genetix). The 380 members of the polymer
libraries were printed following a four-replicate pattern with 1
single field of 32×48 spots containing 4 control (emptied) areas.
Printing conditionswereas follows: 5 stampingsper spot, 200 ms
inking time, and 10 ms stamping time. The typical spot size was
300–320 μm in diameterwith a pitch distance of 560 μm(y-axis)
and 750 μm (x-axis), allowing up to 1520 features to be printed
on a standard 25×75 mm slide. Once printed, the slides were
dried under vacuum (12 h at 42 °C/200 mbar) and sterilised in a
bio-safety cabinet by exposure to UV irradiation for 20 min prior
to use.Polymer library screening
Image capture and analyses were carried out using a high-
content screening (HCS) platform (Nikon 50i fluorescence
microscope (x20 objective) with an X-Y-Z stage), equipped
with Pathfinder software package as described (Pernagallo et
al., 2009; Tourniaire et al., 2006). Cell number (Hoechst 33342:
ex/em 355/465 nm) and hepatic function (monoclonal antibody
against albumin followed by incubation with a fluorescein-
conjugated secondary antibody: ex/em 492/516 nm) (Invitro-
gen) for each polyurethane and polyacrylate member were
determined using fluorescent (DAPI, FITC-like bandpass filters)
channel by automated scanning of polymer spots. For large-
scale analysis of the “hit” polymers 13-mm-diameter glass
coverslips (CB00500RA1, Menzel-Gläser) were cleaned with
tetrahydrofuran (THF) and coated with the polymer. This was
achieved by spotting 100 μl of a solution of the polyurethanes
(134, 212, 223) or polyacrylates (2BG9, 9 G7, 3AA7) (2.0%w/v in
THF) onto the coverslips and spin-coating for 10 s at 2000 rpm.
Coverslips were dried under vacuum (12 h at 45 °C/200 mbar)
and irradiated with UV light for 20 min before use as previously
reported (Pernagallo et al., 2009; Tourniaire et al., 2006).Synthesis of polymer 134
Polyurethane 134 was prepared by the reaction of 1.0 eq of
poly[1,6-hexanediol/neopentyl glycol/di(ethylene glycol)-alt-
101Polymer matrix promotes hepatocyte drug metabolismadipic acid] diol with 2.0 eq of a 4,4′-methylenebis(phenyl
isocyanate) in dry THF, followed by the addition of 1.0 eq of a
1,4-butanediol chain extender accordingly to the schematic
shown in Supplementary Fig. 3. Polymer 134 was fully
characterized (as were all polymers used in the library screen)
using GPC (column PLgel HTS-D 150×7.5 mm i.d., Polymer
Laboratories, NMP 1 ml minute), Hyper DSC (Diamond, Perkin-
Elmer), wettability measurements (Pernagallo et al., 2009),
and FTIR (Mattson instrument).
Scanning electron microscopy
HE was plated and maintained on uncoated and polymer 134-
coated bio-artificial liver matrix for 15 days. At Day 24 HE
maintained on both matrices was fixed with 2.5% glutaral-
dehyde for 2 h at room temperature and washed twice with
0.1 M cacodylate buffer. Following which the samples were
postfixed with 1% osmium tetroxide for 1 h at room
temperature, dehydrated through graded ethanol (50, 70,
90, and 100%), critical point-dried in CO2, and gold-coated by
sputtering. The samples were visualised using a Philips
XL30CP scanning electron microscope.
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